• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Exploring gestational weight gain and newborn birth weight

Exploring gestational weight gain and newborn birth weight

by Truveta Research | Oct 2, 2025 | Research, Research Insights

Mothers who gained more weight during pregnancy had heavier infants and mothers who lost weight during pregnancy had lighter infants. Mothers who gained less weight (particularly <15 pounds) and who lost weight during their pregnancy had increased risk of a...
Exploring gestational weight gain and loss

Exploring gestational weight gain and loss

by Truveta Research | Oct 2, 2025 | Research, Research Insights

Across their pregnancies, mothers had an average of 12 weight measurements, allowing us to construct a longitudinal ‘journey’ of their weight change. Mothers gained an average of 31 pounds across their pregnancies and 45% of mothers had evidence of some weight loss....
Boston Scientific finds reduced infection risk with pressure monitoring ureteroscope

Boston Scientific finds reduced infection risk with pressure monitoring ureteroscope

by Truveta staff | Sep 30, 2025 | Research

Infections secondary to elevated intrarenal pressure and intrarenal backflow remain one of the most concerning complications following ureteroscopy (URS), a common procedure to examine or treat kidney stones. Even though URS is considered a safe and routine procedure,...
Truveta experts: Adoption of MRSA testing for guiding treatment decisions

Truveta experts: Adoption of MRSA testing for guiding treatment decisions

by Truveta staff | Sep 25, 2025 | Research

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most serious infections, often leading healthcare providers to start powerful, broad-spectrum antibiotics like intravenous (IV) vancomycin. While vancomycin can be life-saving, unnecessary use...
Real-world analysis links Dexcom CGM use to reduced progression of chronic kidney disease

Real-world analysis links Dexcom CGM use to reduced progression of chronic kidney disease

by Truveta staff | Sep 16, 2025 | Research

Continuous glucose monitoring (CGM) is increasingly recognized not only for its role in diabetes management but also for its potential impact on broader health outcomes. A recent consensus statement highlighted the need for additional evidence on CGM use in people...
Truveta experts: Gestational diabetes screening in real-world practice

Truveta experts: Gestational diabetes screening in real-world practice

by Truveta staff | Sep 15, 2025 | Research

Gestational diabetes is one of the most common complications of pregnancy, affecting roughly 5–9% of pregnancies in the United States. When diagnosed and managed early, patients can avoid complications such as high birth weight, preterm delivery, or cesarean section....
« Older Entries
Next Entries »

Share this


Recent posts

  • Exploring anemia burden and treatment patterns in patients with chronic kidney disease and diabetes
  • GLP-1 RA prescription trends: January 2018 – September 2025
  • Associations of nutrition counseling, insulin, and metformin therapy with post-GTT weight gain in a large pregnancy cohort

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.